IMS Health files for IPO after making string of tech takeovers

IMS Health has filed papers for an initial public offering (IPO) that Reuters reports could value the private equity-owned company at $10 billion. The IPO could raise up to $100 million as TPG Capital Funds and other investors look to cash in on the business they took private in 2010 in a $5.2 billion deal. Since then, IMS has made a string of acquisitions to add to its analytics capabilities. Article | Filing

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.